• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
Journal of Advanced Biomedical and Pharmaceutical Sciences
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 8 (2025)
Volume Volume 7 (2024)
Volume Volume 6 (2023)
Volume Volume 5 (2022)
Volume Volume 4 (2021)
Volume Volume 3 (2020)
Volume Volume 2 (2019)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 1 (2018)
Qelliny, M., Elgarhy, O., Khaled, K., Aly, U. (2019). Colon Drug Delivery Systems for the Treatment of Inflammatory Bowel Disease.. Journal of Advanced Biomedical and Pharmaceutical Sciences, 2(4), 164-184. doi: 10.21608/jabps.2019.14835.1052
Milad Reda Qelliny; Omar Helmy Elgarhy; Khaled Aly Khaled; Usama Farghly Aly. "Colon Drug Delivery Systems for the Treatment of Inflammatory Bowel Disease.". Journal of Advanced Biomedical and Pharmaceutical Sciences, 2, 4, 2019, 164-184. doi: 10.21608/jabps.2019.14835.1052
Qelliny, M., Elgarhy, O., Khaled, K., Aly, U. (2019). 'Colon Drug Delivery Systems for the Treatment of Inflammatory Bowel Disease.', Journal of Advanced Biomedical and Pharmaceutical Sciences, 2(4), pp. 164-184. doi: 10.21608/jabps.2019.14835.1052
Qelliny, M., Elgarhy, O., Khaled, K., Aly, U. Colon Drug Delivery Systems for the Treatment of Inflammatory Bowel Disease.. Journal of Advanced Biomedical and Pharmaceutical Sciences, 2019; 2(4): 164-184. doi: 10.21608/jabps.2019.14835.1052

Colon Drug Delivery Systems for the Treatment of Inflammatory Bowel Disease.

Article 4, Volume 2, Issue 4, October 2019, Page 164-184  XML PDF (1.49 MB)
Document Type: Review Articles
DOI: 10.21608/jabps.2019.14835.1052
View on SCiNiTO View on SCiNiTO
Authors
Milad Reda Qelliny email orcid ; Omar Helmy Elgarhy; Khaled Aly Khaled; Usama Farghly Alyorcid
Department of Pharmaceutics, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt
Abstract
Inflammatory bowel disease (IBD) is one of the most common chronic diseases that affect the entire gastrointestinal tract (GIT) especially the colon. Its symptoms extend from mild diarrhea, abdominal pain, and bloody diarrhea to severe conditions which affect the quality of life. Many treatments have been developed to treat and cure IBD and to improve patient’s quality of life. The big challenge faces the newly developed treatments is the site of action as the colon presents at the distal end of the GIT and have a complex biological environment. Many technologies have been investigated to target the colon, load higher amounts of active ingredients, and decrease unwanted side effects resulted from upper GIT absorption. This review briefly discusses the IBD, treatment lines, physiological considerations, and all methods of colon targeting technologies starting from the traditional methods which based on pH, time, and microbial content of the colon. Also, we discussed in detail all new techniques based on Micro and Nanotechnology which improve the effectiveness of used therapeutics.
Keywords
inflammatory bowel disease; colon drug delivery systems; OROS-CT; pH-dependent carriers; novel colon approaches
Main Subjects
Pharmaceutics
Statistics
Article View: 1,042
PDF Download: 1,996
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.